Share This

Public company info - Kingworld Medicines Group Ltd. , 01110.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Kingworld Medicines Group Ltd., 01110.HK - Cash Flow 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12
Net Cash Flow from Operating Activities 152,023 87,295 97,186 22,727 118,402 2,311 -37,732 85,716 -38,153 21,386 170,395 59,969 -116,931
Net Cash Flow from Return on Investments & Servicing of Finance -28,141 -46,772 -54,609 -17,478 -15,522 -23,575 -12,753 -21,351 -21,698 -35,207 -5,129 -59,254 -6,895
　Interest Received 1,695 4,125 2,482 3,036 8,346 2,100 4,958 1,671 2,198 4,862 4,481 5,016 2,063
　Interest Paid -15,484 -17,003 -21,559 -14,786 -14,468 -6,813 -3,330 -2,583 -4,690 -8,032 -9,610 -16,570 -8,958
　Dividend Received 8,106 21,678 22,306 2,070 0 0 0 0 0 0 0 0 0
　Dividend Paid -22,458 -55,572 -57,838 -7,798 -9,400 -18,862 -14,381 -20,439 -19,206 -32,037 0 -47,700 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -19,312 -24,910 -24,798 -26,478 -15,612 -7,541 -12,117 -17,336 -15,173 -7,970 -7,928 -8,466 -5,611
Net Cash Flow from Investing Activities -17,485 -8,411 -559 -22,916 -176,474 -31,821 23,146 -90,597 -16,619 -1,685 -8,653 -47,446 -2,000
　Additions to Fixed Assets -20,288 -11,864 -40,125 -11,380 -6,259 -1,973 -1,866 -597 -6,623 -1,685 -1,074 -47,454 -2,020
　Disposal of Fixed Assets 0 4 67 0 0 2 12 0 4 0 4 8 20
　Increase in Investments -726,700 -1,119,351 -25,700 -76,448 -200,065 0 0 0 0 0 0 0 0
　Decrease in Investments 729,503 1,122,800 65,199 83,900 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 490 0 0 0 0 0 0 0 0 0 0 0 79,000
　Others -490 0 0 -18,988 29,850 -29,850 25,000 -90,000 -10,000 0 -7,583 0 -79,000
Net Cash Flow before Financing Activities 87,085 7,202 17,220 -44,145 -89,206 -60,626 -39,456 -43,568 -91,643 -23,476 148,685 -55,197 -131,437
Net Cash Flow from Financing Activities -136,456 -86,472 -3,773 143,636 22,980 169,753 50,237 -7,240 -28,395 212,153 -96,211 37,915 134,161
　New Loans 216,620 647,238 287,595 154,658 167,560 437,081 38,498 12,712 57,873 143,611 247,538 431,167 224,333
　Loans Repayment -348,036 -733,710 -175,572 -11,022 -228,677 -306,782 0 0 -208,551 -252,371 -200,527 -358,905 -172,676
　Fixed Income/Debt Instruments 0 0 0 0 0 105,448 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 -115,796 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 206,167 1 0 0
　Net Cash Flow with Related Parties 490 0 0 0 0 0 0 0 0 0 0 0 79,000
　Others -5,530 0 0 0 84,097 -65,994 11,739 -19,952 122,283 114,746 -143,223 -34,347 3,504
Increase(Decrease) in Cash & Cash Equivalents -49,371 -79,270 13,447 99,491 -66,226 109,127 10,781 -50,808 -120,038 188,677 52,474 -17,282 2,724
Cash & Cash Equivalents at Beginning of Year 160,660 232,755 229,984 132,478 200,178 91,416 83,262 133,833 269,526 83,562 31,240 48,444 45,712
Net Cash Flow due to Change in Exchange Rate/Others 2,206 7,175 -10,676 -1,985 -1,474 -365 -2,627 237 -8,447 -2,713 -152 78 8
Cash & Cash Equivalents at End of Year 113,495 160,660 232,755 229,984 132,478 200,178 91,416 83,262 141,041 269,526 83,562 31,240 48,444
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.